Fig. 4
From: Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction
Mean change in the estimated glomerular filtration rate (eGFR) over time in the esaxerenone monotherapy (a) and add-on therapy (b) studies (safety analysis set). Values are shown as the mean ± SD. Arrows indicate dose escalation visits. BL baseline
